National champions: Costs and benefits of India’s new growth model
By the very concept, “national champions” are state-backed, too big to fail, too powerful for normal laws, scrutiny, regulatory oversights and too big to compete with
growth model
March 2023
August 2012
The pills that saved Ranbaxy
Lipitor's generic and the new anti-malaria drug are good news, but will the consent decree spoil the party?
